5th Annual Heart Team Summit

Friday, September 29, 2023, 7:00 AM - Saturday, September 30, 2023, 12:00 PM, JW Marriott Indianapolis, Indianapolis, IN


A Heart Team is now a standard treatment approach for complex cardiovascular patients. The Heart Team consists of cardiologists, cardiac surgeons, nurses and other health care specialists. This includes regular meetings to make consensus treatment recommendations for conditions including obstructive coronary artery disease and valvular heart conditions. This conference will provide expert lectures and case presentations geared toward health care professionals who may be part of a Heart Team, including the latest innovations as well as standard treatments such as transcatheter valvular heart therapies and coronary revascularization strategies.

1. Recognize appropriate patient selection and referral for surgical versus percutaneous/transcatheter mitral and aortic valve intervention
2. Apply various diagnostic technologies including transthoracic echocardiography, intracardiac echocardiography, TEE, CT, and CMR to guide management of valvular heart disease
3. Describe the concept of the Heart Team, including the key components and functionality
4. List transcatheter options to address heart valve pathology including aortic, mitral, tricuspid and pulmonic stenosis and regurgitation
5. Identify the indications for LA appendage closure and the available and emerging technologies to manage the left atrial appendage and how it can mitigate stroke.
6. Describe the latest interventional and surgical techniques and therapies for structural heart disease and congenital heart disease
7. Describe the differences in outcomes in valvular and coronary pathology in men and women
8. Describe the racial disparities encountered in cardiovascular health.
9. Choose and utilize appropriately the various hemodynamic support and interventional/surgical tools to assist in the management of cardiogenic shock
10. Summarize the latest developments and the current guidelines on the appropriate use of surgical and percutaneous coronary revascularization
11. Identify how to evaluate, follow, refer and treat patients with thoracic aneurysms
12. Implement the latest guidelines when evaluating/imaging the patient with suspected coronary artery disease

Early Bird Rates (through 8/1/2023)

Early Bird Registration: $195

Fellow/Resident/Trainee*: Complimentary

Regular Rates (after 8/1/2023)

Regular Registration: $250

Fellow/Resident/Trainee*: Complimentary

*Fellows may be asked to provide a letter from their Program Director. 

Fellows and residents may also email [email protected] to register as well. 

Registration will close on September 27, 2023 at 5:00 PM CT. On-site registration will be available.

Refunds/Cancellations

Cancellations must be made in writing to [email protected]. The paid registration fee will be refunded if cancellation is received by August 29, 2023. No refunds will be issued after this date.

Please contact Amanda Harrison at [email protected] with any questions.

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (11.75 hours), ABIM MOC Part 2 (10.75 hours), Non-Physician Attendance (11.75 hours)

Heart Team Summit Course Directors

Mitigation of Relevant Financial Relationships

Feinberg School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a Continuing Education activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.